Crossmark

The risk of hypocalcaemia after denosumab administration

Crossref DOI link: https://doi.org/10.1007/s00198-026-07919-5

Published Online: 2026-02-23

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Whelan, Alice

Brennan, Finlay

Lannon, Rosaleen

Fitzpatrick, Donal

McCarroll, Kevin https://orcid.org/0009-0008-9809-1014
License Information

Text and Data Mining valid from 2026-02-23

Version of Record valid from 2026-02-23
More Information

Article History

Received: 6 February 2026

Accepted: 16 February 2026

First Online: 23 February 2026

Declarations

:

: None.